mortality/aging
• survival compared to wild-type mice decreases after 25 months of age with all mice dead by 30 months
|
neoplasm
• young mice develop fewer and smaller tumors in a classical skin carcinogenesis protocol (DMBA and TPA induction) compared to similarly treated wild-type mice
|
• young mice develop fewer and smaller tumors in a classical skin carcinogenesis protocol (DMBA and TPA induction) compared to similarly treated wild-type mice
|
• aged mice develop more frequent epithelial neoplasias such as mammary adenocarcinomas and fibroadenomas (in females) as well as tumors in the lung, liver, kidney, testis and sebaceous glands compared to wild-type mice
|
• aged female mice develop mammary adenocarcinomas and fibroadenomas more frequently than wild-type mice
|
• in aged female mice
|
• in aged mice
|
• in aged mice
|
• in aged mice
|
nervous system
• mice exhibit increased proliferation in cells of the subventricular zone
• however, no alterations in brain structures are detected
|
behavior/neurological
• object recognition is reduced compared to in wild-type mice
|
• mice exhibit increased falling off of a circular rod compared to wild-type mice
|
homeostasis/metabolism
• young mice develop fewer and smaller tumors in a classical skin carcinogenesis protocol (DMBA and TPA induction) compared to similarly treated wild-type mice
|
endocrine/exocrine glands
• aged female mice develop mammary adenocarcinomas and fibroadenomas more frequently than wild-type mice
|
• in aged female mice
|
• in aged mice
|
reproductive system
• in aged mice
|
integument
• aged female mice develop mammary adenocarcinomas and fibroadenomas more frequently than wild-type mice
|
• in aged female mice
|
respiratory system
• in aged mice
|
liver/biliary system
• in aged mice
|